Globus Medical is gaining market share in the musculoskeletal solutions space, banking on the strong performance of its implantable devices, biologics, accessories and unique surgical instruments used in an expansive range of spinal, orthopedic and neurosurgical procedures. The combination capitalizes on GMED’s complementary commercial organization and should allow the company to accelerate its globalization strategies to increase customer reach and strengthen surgeon relationships. Meanwhile, like other industry players, GMED is currently grappling with negative trends in the global economy, including interest rate fluctuations, increases in inflation and financial market volatility.
finance news